Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update

Presented data at ESMO 2025 demonstrating promising efficacy with CRB-701 in head and neck squamous cell carcinoma (HNSCC) and cervical cancerCRB-701 data for both indications is expected in mid-2026 ...
American Association of Individual Investors

Which Is a Better Investment, ACADIA Pharmaceuticals Inc. or Xenon Pharmaceuticals Inc. Stock?

Learn more about whether ACADIA Pharmaceuticals Inc. or Xenon Pharmaceuticals Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Lincoln National Corporation: High Yield Plus Capital Appreciation

Lincoln National Corporation offers a 5.29% dividend yield, annuity growth, and potential 35% upside. Click here to read an analysis of LNC stock now.
The Manila Times

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update

Presented data at ESMO 2025 demonstrating promising efficacy with CRB-701 in head and neck squamous cell carcinoma (HNSCC) ...

Board Approves Higginsville Expansion Plan

Westgold Resources Limited (ASX: WGX) (TSX: WGX) (Westgold or the Company) is pleased to announce that its Board has approved ...
News 13

A final farewell to Universal Studios' Shrek 4-D

ORLANDO, Fla. — It's time to say farewell to Shrek 4-D, Universal Studios Florida's long-running attraction that features the most famous big green ogre on the planet. After nearly 19 years of ...